Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume 40, Issue 14, Pages 6725-6740
Publisher
Oxford University Press (OUP)
Online
2012-05-05
DOI
10.1093/nar/gks360
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic reprogramming of cancer cells via targeted DNA methylation
- (2012) Ashley G. Rivenbark et al. Epigenetics
- Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
- (2011) Claudia Lengerke et al. BMC CANCER
- Reactivation ofMASPINin non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs)
- (2011) Adriana S. Beltran et al. Epigenetics
- SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer
- (2011) Theresia Wilbertz et al. MODERN PATHOLOGY
- SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells
- (2011) Felix Oppel et al. Molecular Cancer
- Dnmt3a is essential for hematopoietic stem cell differentiation
- (2011) Grant A Challen et al. NATURE GENETICS
- Sox2 expression in breast tumours and activation in breast cancer stem cells
- (2011) O Leis et al. ONCOGENE
- Suppression of Breast Tumor Growth and Metastasis by an Engineered Transcription Factor
- (2011) Adriana S. Beltran et al. PLoS One
- Genetic and Epigenetic Modifications of Sox2 Contribute to the Invasive Phenotype of Malignant Gliomas
- (2011) Marta M. Alonso et al. PLoS One
- Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
- (2010) S. Y. Park et al. CLINICAL CANCER RESEARCH
- Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer
- (2010) Yunching Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic control of embryonic stem cell fate
- (2010) Nicolaj Strøyer Christophersen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An Engineered Zinc Finger Protein Activator of the Endogenous Glial Cell Line-Derived Neurotrophic Factor Gene Provides Functional Neuroprotection in a Rat Model of Parkinson's Disease
- (2010) J. Laganiere et al. JOURNAL OF NEUROSCIENCE
- Expression of Pluripotent Stem Cell Reprogramming Factors by Prostate Tumor Initiating Cells
- (2010) Kyung-Mi Bae et al. JOURNAL OF UROLOGY
- Repression of Human Telomerase Reverse Transcriptase Using Artificial Zinc Finger Transcription Factors
- (2010) J. H. Sohn et al. MOLECULAR CANCER RESEARCH
- Molecular Stratification of Triple-Negative Breast Cancers
- (2010) C. M. Perou ONCOLOGIST
- SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas
- (2010) Thomas Hussenet et al. PLoS One
- Evidence That SOX2 Overexpression Is Oncogenic in the Lung
- (2010) Yun Lu et al. PLoS One
- Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
- (2010) Elaine Lai-Han Leung et al. PLoS One
- Mesenchymal/Stromal Gene Expression Signature Relates to Basal-Like Breast Cancers, Identifies Bone Metastasis and Predicts Resistance to Therapies
- (2010) Cristina Marchini et al. PLoS One
- KRAB–Zinc Finger Proteins and KAP1 Can Mediate Long-Range Transcriptional Repression through Heterochromatin Spreading
- (2010) Anna C. Groner et al. PLoS Genetics
- Zinc-finger-based artificial transcription factors and their applications
- (2009) Takashi Sera ADVANCED DRUG DELIVERY REVIEWS
- Embryonic stem cell markers expression in cancers
- (2009) Matthieu Schoenhals et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
- (2009) Ann F. Chambers CANCER RESEARCH
- Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
- (2009) B. T. Hennessy et al. CANCER RESEARCH
- The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor
- (2009) Xiao-Lan Xu et al. CARCINOGENESIS
- Epigenetic reprogramming and induced pluripotency
- (2009) K. Hochedlinger et al. DEVELOPMENT
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
- (2009) Adam J Bass et al. NATURE GENETICS
- SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis
- (2008) T Otsubo et al. BRITISH JOURNAL OF CANCER
- Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation
- (2008) Bernardina T.F. van der Gun et al. INTERNATIONAL JOURNAL OF CANCER
- The Molecular Mechanism Governing the Oncogenic Potential of SOX2 in Breast Cancer
- (2008) Yupeng Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic modifications ofSOX2 enhancers, SRR1 and SRR2, correlate with in vitro neural differentiation
- (2008) Marianna Sikorska et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Modulation of drug resistance by artificial transcription factors
- (2008) P. Blancafort et al. MOLECULAR CANCER THERAPEUTICS
- Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor
- (2008) A. S. Beltran et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
- De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes
- (2008) Silvina Epsztejn-Litman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- SOX2Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
- (2008) Rosaria Maria Rita Gangemi et al. STEM CELLS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now